Page 107 - 《中国药房》2024年2期
P. 107
1446. HA C Z,WANG K,LI W,et al. Clinical effect of low
[16] WATTS P J,KOPSTEIN M,HARKNESS W,et al. A molecular weight heparin combined with aspirin in
retrospective analysis of bleeding risk with rivaroxaban, preventing deep venous thrombosis after hip and knee
enoxaparin,and aspirin following total joint arthroplasty joint replacement[J]. China Mod Med,2020,27(6):
or revision[J]. Pharmacotherapy,2021,41(7):608-615. 12-16.
[17] REN Y,CAO S L,LI Z,et al. Comparable efficacy of 100 [24] HOOD B R,COWEN M E,ZHENG H T,et al. Associa‐
mg aspirin twice daily and rivaroxaban for venous throm‐ tion of aspirin with prevention of venous thromboembo‐
boembolism prophylaxis following primary total hip lism in patients after total knee arthroplasty compared
arthroplasty:a randomized controlled trial[J]. Chin Med J, with other anticoagulants:a noninferiority analysis[J].
2021,134(2):164-172. JAMA Surg,2019,154(1):65-72.
[18] 张慧,赵轶男,孙强,等. 高龄患者人工股骨头置换术后 [25] ANDERSON D R,DUNBAR M,MURNAGHAN J,et al.
应用阿司匹林预防静脉血栓形成的效果观察[J]. 中国骨 Aspirin or rivaroxaban for VTE prophylaxis after hip or
与关节损伤杂志,2021,36(12):1292-1294. knee arthroplasty[J]. N Engl J Med,2018,378(8):
ZHANG H,ZHAO Y N,SUN Q,et al. Observation on the 699-707.
effect of aspirin in preventing venous thrombosis after arti‐ [26] 张杭,张志强,贺强,等. 阿司匹林预防全膝关节置换后
ficial femoral head replacement in elderly patients[J]. 静脉血栓的有效及安全性[J]. 中国组织工程研究,2018,
Chin J Bone Jt Inj,2021,36(12):1292-1294. 22(15):2321-2326.
[19] 平伟,王伟,宋巍,等. 氨甲环酸联合阿司匹林对老年人 ZHANG H,ZHANG Z Q,HE Q,et al. Efficacy and
工全膝关节置换术围术期出血量、膝关节功能恢复及内 safety of aspirin for venous thromboembolism after total
皮功能的影响[J]. 解放军医药杂志,2021,33(4):70-74. knee arthroplasty[J]. Chin J Tissue Eng Res,2018,22
PING W,WANG W,SONG W,et al. Effects of (15):2321-2326.
tranexamic acid combined with aspirin on perioperative [27] 郝明,李文雅. 阿司匹林与利伐沙班预防全膝关节置换
volume of blood loss,knee joint function recovery and 后下肢深静脉血栓的临床对照研究[J]. 药物评价研究,
endothelial function in elderly patients undergoing total 2017,40(6):824-827.
knee arthroplasty[J]. Med Pharm J Chin People’s Liberation HAO M,LI W Y. Clinical control study on efficacy of
Army,2021,33(4):70-74. aspirin and rivaroxaban on prevention of deep vein throm‐
[20] MATHARU G S,GARRIGA C,WHITEHOUSE M R,et bosis after total knee replacement[J]. Drug Eval Res,
al. Is aspirin as effective as the newer direct oral anticoa- 2017,40(6):824-827.
gulants for venous thromboembolism prophylaxis after [28] 刘泽朋,荣绍远,李春洪,等. 阿司匹林预防膝关节置换
total hip and knee arthroplasty? An analysis from the 术后下肢深静脉血栓的疗效和安全性[J]. 医学信息,
national joint registry for England,Wales,Northern 2017,30(2):111-113.
Ireland,and the Isle of Man[J]. J Arthroplasty,2020,35 LIU Z P,RONG S Y,LI C H,et al. Efficacy and safety of
(9):2631-2639.e6. aspirin in prevention of DVT of lower limbs after total
[21] NÍ CHEALLAIGH S,FLEMING A,DAHLY D,et al. knee arthroplsaty[J]. J Med Inf,2017,30(2):111-113.
Aspirin compared to enoxaparin or rivaroxaban for thrombo- [29] ANDERSON D R,DUNBAR M J,BOHM E R,et al.
prophylaxis following hip and knee replacement[J]. Int J Aspirin versus low-molecular-weight heparin for extended
Clin Pharm,2020,42(3):853-860. venous thromboembolism prophylaxis after total hip
[22] BALA A,MURASKO M J,BURK D R,et al. Venous arthroplasty:a randomized trial[J]. Ann Intern Med,2013,
thromboprophylaxis after total hip arthroplasty:aspirin, 158(11):800-806.
warfarin,enoxaparin,or factor Ⅹa inhibitors?[J]. Hip Int, [30] SHARDA A V,FATOVIC K,BAUER K A. Aspirin throm‐
2020,30(5):564-571. boprophylaxis in joint replacement surgery[J]. Res Pract
[23] 哈承志,王凯,李伟,等. 低分子肝素联合阿司匹林预防 Thromb Haemost,2022,6(1):e12649.
髋、膝关节置换术后深静脉血栓形成的临床效果[J]. 中 (收稿日期:2023-08-03 修回日期:2023-12-07)
国当代医药,2020,27(6):12-16. (编辑:陈 宏)
中国药房 2024年第35卷第2期 China Pharmacy 2024 Vol. 35 No. 2 · 225 ·